We recently published a list of Traders Heavily Sold Down These 10 Stocks on Thursday. In this article, we are going to take ...

Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for ...

Charles River Associates CRAI has performed extremely well over the past year and has the potential to sustain the momentum in the near term. Consequently, you should add the stock to your portfolio ...

JPMorgan sees a likely negative impact to Charles River (CRL) after the FDA announced it would be reducing its animal testing requirements for ...

FDA introduces a new roadmap to reduce animal testing in monoclonal antibody development using AI models, organoid testing and real-world data to enhance safety and efficiency.

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have earned an average rating of ...

Corebridge Financial Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% during the fourth quarter, according to its most recent disclosure ...